FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer.
about
Integrative genomic analysis identifies that SERPINA6-rs1998056 regulated by FOXA/ERα is associated with female hepatocellular carcinoma.Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations.Clinicopathological significance of forkhead box protein A1 in breast cancer: A meta-analysis.Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis.The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy.
P2860
FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
FOXA1 expression after neoadju ...... ceptor-positive breast cancer.
@en
FOXA1 expression after neoadju ...... ceptor-positive breast cancer.
@nl
type
label
FOXA1 expression after neoadju ...... ceptor-positive breast cancer.
@en
FOXA1 expression after neoadju ...... ceptor-positive breast cancer.
@nl
prefLabel
FOXA1 expression after neoadju ...... ceptor-positive breast cancer.
@en
FOXA1 expression after neoadju ...... ceptor-positive breast cancer.
@nl
P2093
P2860
P1433
P1476
FOXA1 expression after neoadju ...... ceptor-positive breast cancer.
@en
P2093
Hiroko Yamashita
Mai Kawase
Nobuyasu Yoshimoto
Satoru Takahashi
Shinya Sato
Shunzo Kobayashi
Tatsuya Toyama
Tomoko Asano
Yoshitaka Fujii
P2860
P2888
P304
P356
10.1007/S12282-013-0482-2
P577
2013-06-16T00:00:00Z
P5875
P6179
1051878354